简体
  • 简体中文
  • 繁体中文
×

热门资讯> 正文

ABVC BioPharma从OncoX BioPharma获得20万美元现金

2024-12-11 20:16

  • ABVC BioPharma (NASDAQ:ABVC) said it has received a $200K cash payment from OncoX BioPharma as part of its strategic licensing agreement for certain oncology-related products.
  • The payment is the first installment of $5 million in potential licensing fees from OncoX.
  • After this payment, the total accumulated cash payment ABVC has gotten from its three strategic partners for licensing various ABVC products is $546K.

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
问答大全
（工作日09：30 - 次日05：30）
客户端：
关注我们：
  • 微信公众号二维码

© 2025 深圳市时代华盛网络科技有限公司版权所有 粤ICP备16068286号